Lartesertib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lartesertib, covering 2026-02-18 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302) [Phase 2]